Providence Cancer Institute of Oregon

Celebrating World Cancer Day with a look at the work of Carlo Bifulco, M.D. as he helps lead advancements in AI-driven, accessible precision oncology at Providence Cancer Institute.

Providence Cancer Institute researchers share important cancer research at SITC annual meeting and receive recognition for their contributions to science.

Thoracic surgeon and director of Robotic Thoracic Surgery at Providence Cancer Institute shares the latest in lung cancer screening and treatment approaches.

New studies at Providence Cancer Institute offer hope to patients with limited treatment options.

Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.

Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.

A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.

Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.

Two new trials evaluating new medications or combinations of medications for people with ovarian cancer or small cell lung cancer open at Providence Cancer Institute.

Robotic thoracic surgery is less invasive, allowing patients to recover more quickly. A Providence Cancer Institute surgeon calls it a game-changer.

Hands-on experience in a laboratory at Providence Cancer Institute helps undergraduate students find their career path in biomedical fields.

Learn key facts about lung cancer at a free virtual talk hosted by Providence Cancer Institute and Asian Cancer Resource & Support Services.

A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.

A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.

A generous gift of plush blankets helps comfort patients during their chemotherapy treatments at Providence Cancer Institute Newberg Clinic.

Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.

Explore new findings in cancer immunotherapy and clinical research from Providence at ASCO 2025.

Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.

When Randy was diagnosed with small cell lung cancer, he thought it was time to get his affairs in order. But a phase I clinical trial at Providence Cancer Institute gave him more time and hope.